Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
antidepressant
behavior modification
complications
concentration, impaired
conversion reaction
depression
diagnostic criteria
disability, neurological
dizziness
drug induced neurologic disorders
efficacy
episodic disorders
gait disorder
iatrogenic neurologic disorders
imbalance
imbalance, postural
movement disorder, psychogenic
neurologic disease, diagnoses of
Parkinson disease
paroxetine
pathologic reflex
patient information and support
Persistent postural-perceptual dizziness
precipitating factors
prognosis
safety
selective norepinephrine reuptake inhibitor
selective serotonin reuptake inhibitors
serotonin norepinephrine reuptake inhibitors
serotonin syndrome
treatment of neurologic disorder
triptans
venlafaxine
Showing articles 950 to 993 of 993 << Previous

Increased Ratio of Carbidopa to Levodopa in Treatment of Parkinson's Disease
Arch Neurol 37:723-726, Tourtellotte,W.W.,et al, 1980

Sinemet-25/100
Medical Letter, 22:511980., , 1980

Acquired Hemophilia, Meningioma, & Diphenyl-hydantoin Therapy
J Neurosurg 53:600-605, O'Reilly,R.A.,et al, 1980

Anticholinergic Toxicity
NEJM 300:1278, Caine,E.D., 1979

Physostigmine in Reye Syndrome
Ann Neurol 5:105, Pettegrew,J.W.,et al, 1979

Effects of Physostigmine & Lecithin on Memory in Alzheimer Disease
Ann Neurol 6:219-221, Peters,B.H.,et al, 1979

Enhancement Of Memory By Physostigmine
NEJM 301:946, Davis,K.L.,et al, 1979

Meige Disease:Striatal Dopaminergic Preponderance
Neurol 29:1126-1130, Tolosa,E.S.,et al, 1979

Familial Periodic Ataxia
Arch Neurol 36:568-569, Donat,J.R.,et al, 1979

Reversibility of Human Myopathy Caused by Vitamin E Deficiency
Neurol 29:1182-1186, Tomasi,L.G., 1979

Effects of Acetazolamide on Myotonia
Ann Neurol 3:531, Griggs,R.C.,et al, 1978

Considerations in the Management of Parkinsonism
Neurol 28:5, Fahn,S.,et al, 1978

Amantadine Intoxication Reversed by Physostigmine
NEJM 298:516, Casey,D.E., 1978

Comparative Effectiveness of Two Extracerebral DOPA Decarboxylase Inhibitors in Parkinson Disease
Neurol 28:964-968, Lieberman,A.,et al, 1978

Memory Impairment in Korsakoff's Psychosis:A Correlation with Brain Noradrenergic Activity
Science 202:905-907, McEntee,W.J.,et al, 1978

Hereditary Paroxysmal Ataxia:Response to Acetazolamide
Neurol 28:1259-1264, Griggs,R.C.,et al, 1978

Postural Hypotension:Adrenergic Responsivity, & Levodopa Therapy
Neurol 27:921, Corder,C.N.,et al, 1977

A Syndrome of Early Recognition of Occult Hydrocephalus & Cerebral Atrophy
Quart J Med 183:365, Botez,M.I.,et al, 1977

Diffuse"Anoxic"Myelopathy
Neurol 27:1049, Azzarelli,B.,et al, 1977

Clofibrate-Induced Muscle Damage with Myoglobinuria & Cardiomyopathy
NEJM 296:942, Smals,A.G.H., 1977

Malabsorption of Pyridostigmine in Patients with Masthenia Gravis
Neurol 27:299, Cohan,S.L.,et al, 1977

Total Gaze Paresis in Amitriptyline Overdose
Neurol 27:695, Miadinich,E.K.,et al, 1977

Juvenile Parkinsonism Treated with Levodopa
Arch Neurol 34:244, Sachdev,K.K.,et al, 1977

Serotonin & Myoclonic Seizures
NEJM 296:101, Munsat,T.L., 1977

Mild High-Renin Essential Hypertension
NEJM 296:405, Esler,M.,et al, 1977

Physostigmine in Familial Ataxias
Neurol 27:70, Kark,R.A.,et al, 1977

Drug Therapy of Tardive Dyskinesia
NEJM 296:257, Kobayashi,R.M., 1977

Purine Phosphoribosyltransferase in Gilles de la Tourette Syndrome
NEJM 296:210, VanWoert,M.H.,et al, 1977

Pheniramine Aminosalicylate Overdosage:Reversal of Delirium & Choreiform Movements with Tacrine Treatment
Arch Neurol 34:313, Mendelson,G.,et al, 1977

Degeneration of Fasciculus Gracilis in Cystic Fibrosis
Neurol 27:185, Geller,A.,et al, 1977

Drug Therapy of Parkinsonism
NEJM 295:814, Bianchine,J.R., 1976

Neurotransmitters & the Normal & Ischemic Cerebral Circulation
NEJM 293:812, Zervas,N.T.,et al, 1975

Catecholamines & Neurologic Diseases
NEJM 293:274, Moskowitz,M.A.,et al, 1975

Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease
NEJM 293:174, Genton,E.,et al, 1975

Neurotoxicity of Commonly Used Antineoplastic Agents
NEJM 291:75, 1271974., Weiss,H.,et al, 1974

Post-Herpes Zoster Neuralgia:Response to Vitamin E Therapy
Arch Dermatol 108:855, Ayres,S.Jr.,et al, 1973

The Treatment of Cerebrovascular Disease with Clofibrate
VA Cooperative Study Group, Stroke 4:6841973., , 1973

Huntington's Chorea, Effect of Serotonin Depletion
Arch Neurol 26:282, Chase,T.,et al, 1972

Clofibrate for the Treatment of Occlusive CVD-Correspondence
NEJM 287:671, Hirsch,S.,et al, 1972

Drug Therapy of Parkinsonism
NEJM 287:20, Yahr,M.,et al, 1972

Effect of Chronic Anticonvulsant Therapy on Serum 25-Hydroxycalciferol Levels in Adults
NEJM 287:898, Hahn,T.,et al, 1972

Muscular Syndrome after Clofibrate
NEJM 286:1110, Katsilambros,N., 1972

Hypokalemic Periodic Paralysis withArrhythmia
NEJM 286:253, Levitt,L.,et al, 1972

Monoamine Oxidase Inhibitor & L-Dopa
BMJ 3:388, Hunter,H.R.,et al, 1970



Showing articles 950 to 993 of 993 << Previous